BlackRock Institutional Trust’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$31M	Buy	1,228,844 +79,600	+7%	+$1.78M	﹤0.01%	1644
2016 Q3	$28.4M	Buy	1,149,244 +165,346	+17%	+$3.74M	﹤0.01%	1638
2016 Q2	$20M	Buy	983,898 +98,057	+11%	+$1.74M	﹤0.01%	1847
2016 Q1	$13.5M	Buy	885,841 +12,073	+1%	+$158K	﹤0.01%	2072
2015 Q4	$11.7M	Buy	873,768 +32,103	+4%	+$497K	﹤0.01%	2221
2015 Q3	$11.8M	Buy	841,665 +235,695	+39%	+$4.38M	﹤0.01%	2177
2015 Q2	$10.3M	Buy	605,970 +230,538	+61%	+$3.28M	﹤0.01%	2390
2015 Q1	$4.54M	Buy	375,432 +98,299	+35%	+$929K	﹤0.01%	2791
2014 Q4	$2.3M	Sell	277,133 -3,194	-1%	-$26.8K	﹤0.01%	3043
2014 Q3	$2.44M	Sell	280,327 -25,413	-8%	-$230K	﹤0.01%	2990
2014 Q2	$3.35M	Buy	305,740 +111,669	+58%	+$995K	﹤0.01%	2953
2014 Q1	$1.74M	Buy	194,071 +46,045	+31%	+$424K	﹤0.01%	3218
2013 Q4	$1.12M	Sell	148,026 -7,416	-5%	-$51.9K	﹤0.01%	3365
2013 Q3	$1.14M	Buy	155,442 +6,817	+5%	+$45.8K	﹤0.01%	3325
2013 Q2	$956K	Buy	+148,625	New	+$875K	﹤0.01%	3340